{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:33:52Z","timestamp":1775032432246,"version":"3.50.1"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Research on the therapeutic effects of psychedelics in psychiatry, commonly referred to as Psychedelic-Assisted Therapy (PAT), has expanded substantially in recent years. The context-dependent nature of psychedelics has sparked discussion about the importance of the psychotherapeutic environment in achieving beneficial outcomes. This study explores the contribution of psychotherapeutic factors on PAT in Switzerland, where psychedelic treatments can be implemented within long-term clinical frameworks. Seven semi-structured interviews were conducted with Swiss therapists to explore how they frame psychedelic treatments and the role of the psychotherapeutic setting in facilitating therapeutic outcomes. Thereby, individual experiences of the patients as reported by the therapists, were particularly considered. Thematic analysis identified two main themes, each with several sub-themes. The first theme revealed that while psychotherapeutic techniques are adapted to PAT, they retain similarities to non-psychedelic psychotherapy practices, supporting patients in having meaningful therapeutic experiences. The second theme describes a synergistic relationship between psychedelics and psychotherapy, amplifying underlying general psychotherapeutic factors such as trust, a sense of profundity, and the emergence of therapeutic experiences. The interviewed therapists agreed that psychedelics work as unspecific catalysts for psychotherapeutic processes, while still acknowledging the potential for psychopharmacological effects or the interaction between psychedelics and psychotherapy to create unique psychotherapeutic processes. Findings from our sample suggest that, for specific indications, incorporating psychedelics into long-term psychotherapeutic treatment may strengthen therapeutic processes. Future research could investigate the efficacy of PAT within the framework of specific psychotherapeutic modalities or in different settings, including prospective quantitative assessments of outcomes. Ultimately, clarifying mechanisms of action of PAT may help to enhance its efficacy and potentially to integrate psychedelic treatments into mainstream mental health care.<\/jats:p>","DOI":"10.3389\/fpsyt.2026.1771726","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:41:27Z","timestamp":1775022087000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergies in psychedelic-assisted therapy: a qualitative interview study of psychotherapeutic processes"],"prefix":"10.3389","volume":"17","author":[{"given":"Jonathan","family":"Stellmacher","sequence":"first","affiliation":[{"name":"Institut f\u00fcr Psychologie, Universit\u00e4t Greifswald","place":["Greifswald, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Schmidt","sequence":"additional","affiliation":[{"name":"MIND Foundation","place":["Berlin, Germany"]},{"name":"Department of Psychology, Humboldt-Universit\u00e4t zu Berlin","place":["Berlin, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena D.","family":"Aicher","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Substance-Assisted Therapy, Division of Medicine, University of Basel","place":["Basel, Switzerland"]},{"name":"Swiss Medical Society for Psychedelic Therapy (S\u00c4PT)","place":["Berne, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kae","family":"Eichel","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Psychologie, Universit\u00e4t Greifswald","place":["Greifswald, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva-Lotta","family":"Brakemeier","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Psychologie, Universit\u00e4t Greifswald","place":["Greifswald, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Herwig","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Center for Psychiatry Reichenau","place":["Reichenau, Germany"]},{"name":"Departement of Psychiatry and Psychotherapy III, Universit\u00e4t Ulm","place":["Ulm, Germany"]},{"name":"University Hospital of Psychiatry, Universit\u00e4t Z\u00fcrich","place":["Z\u00fcrich, Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2020.03.017","article-title":"Long-term effects of psychedelic drugs: A systematic review","volume":"113","author":"Aday","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1176\/appi.ajp.20241025","article-title":"Psychedelics in psychiatry: oh, what A trip","volume":"182","author":"Fonzo","year":"2025","journal-title":"Am J Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1176\/appi.ajp.2019.19010035","article-title":"Psychedelics and psychedelic-assisted psychotherapy","volume":"177","author":"Reiff","year":"2020","journal-title":"Am J Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e078084","DOI":"10.1136\/bmj-2023-078084","article-title":"Efficacy of psilocybin for treating symptoms of depression: Systematic review and meta-analysis","volume":"385","author":"Metaxa","year":"2024","journal-title":"BMJ (Clinical Res Ed.)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/npr2.12485","article-title":"Mdma-assisted psychotherapy for the treatment of PTSD: A systematic review and meta-analysis of randomized controlled trials (RCTs)","volume":"44","author":"Shahrour","year":"2024","journal-title":"Neuropsychopharmacol Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2020.1769878","article-title":"A meta-analysis of placebo-controlled trials of psychedelic-assisted therapy","volume":"52","author":"Luoma","year":"2020","journal-title":"J Psychoactive Drugs"},{"key":"B7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12909-025-06871-y","article-title":"Further education in psychedelic-assisted therapy - experiences from Switzerland","volume":"25","author":"Aicher","year":"2025","journal-title":"BMC Med Educ"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/00048674241240597","article-title":"A taxonomy of regulatory and policy matters relevant to psychedelic-assisted therapy in Australia","volume":"58","author":"Hatfield","year":"2024","journal-title":"Aust New Z J Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13011-022-00468-0","article-title":"Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy","volume":"17","author":"Mocanu","year":"2022","journal-title":"Subst Abuse Treatment Prevention Policy"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-022-01389-z","article-title":"Towards an understanding of psychedelic-induced neuroplasticity","volume":"48","author":"Calder","year":"2023","journal-title":"Neuropsychopharmacology: Off Publ Am Coll Neuropsychopharmacol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/7854_2024_509","article-title":"Set and setting for psychedelic harm reduction","author":"Hartogsohn","year":"2024","journal-title":"Current Topics in Behavioral Neurosciences"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20221043","article-title":"Must psilocybin always \u201cAssist psychotherapy\u201d","volume":"181","author":"Goodwin","year":"2024","journal-title":"Am J Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(23)00363-2","article-title":"Treatment with psychedelics is psychotherapy: Beyond reductionism","volume":"11","author":"Gr\u00fcnder","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1089\/psymed.2023.0007","article-title":"A systematic review of reporting practices in psychedelic clinical trials: psychological support, therapy, and psychosocial interventions","volume":"1","author":"Brennan","year":"2023","journal-title":"Psychedelic Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-022-01363-y","article-title":"The emerging field of psychedelic psychotherapy","volume":"24","author":"Barber","year":"2022","journal-title":"Curr Psychiatry Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4414\/sanp.2024.1488043038","article-title":"Treatment recommendations for psychedelic-assisted therapy","volume":"175","author":"Aicher","year":"2024","journal-title":"Swiss Arch Neurology Psychiatry Psychother"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1177\/02698811241249698","article-title":"Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ)","volume":"38","author":"Wolff","year":"2024","journal-title":"J Psychopharmacol (Oxford England)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10503309712331331843","article-title":"Research-informed psychotherapy","volume":"7","author":"Grawe","year":"1997","journal-title":"Psychother Res"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.4324\/9780203582015","volume-title":"The great psychotherapy debate: The evidence for what makes psychotherapy work","author":"Wampold","year":"2015"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20230665","article-title":"Psychotherapy in psychedelic treatment: safe, evidence-based, and necessary","volume":"181","author":"Alpert","year":"2024","journal-title":"Am J Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20230572","article-title":"Psilocybin without psychotherapy: A cart without a horse","volume":"181","author":"Earleywine","year":"2024","journal-title":"Am J Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2010.08.011","article-title":"The double edged sword of neural plasticity: Increasing serotonin levels leads to both greater vulnerability to depression and improved capacity to recover","volume":"36","author":"Branchi","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1556\/2054.2018.001","article-title":"Inside bad trips: Exploring extra-pharmacological factors","volume":"2","author":"Ona","year":"2018","journal-title":"J Psychedelic Stud"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: Guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J Psychopharmacol (Oxford England)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00005","article-title":"Learning to let go: A cognitive-behavioral model of how psychedelic therapy promotes acceptance","volume":"11","author":"Wolff","year":"2020","journal-title":"Front Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"100104","DOI":"10.1016\/j.nsa.2022.100104","article-title":"Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design","volume":"1","author":"Mertens","year":"2022","journal-title":"Neurosci Appl"},{"key":"B27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/bs13040297","article-title":"Psychotherapy with psilocybin for depression: systematic review","volume":"13","author":"Dawood Hristova","year":"2023","journal-title":"Behav Sci (Basel Switzerland)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e2524119","DOI":"10.1001\/jamanetworkopen.2025.24119","article-title":"Control group outcomes in trials of psilocybin, SSRIs, or esketamine for depression: A meta-analysis","volume":"8","author":"Hieronymus","year":"2025","journal-title":"JAMA Network Open"},{"key":"B29","article-title":"NDA 215455: COMPLETE RESPONSE","year":"2024"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.nsa.2025.105525","article-title":"Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program","volume":"4","author":"Liechti","year":"2025","journal-title":"Neurosci Appl"},{"key":"B31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: Six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"New Engl J Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-024-06620-x","article-title":"Psychedelic-assisted psychotherapy: Where is the psychotherapy research","volume":"241","author":"Aday","year":"2024","journal-title":"Psychopharmacology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.788155","article-title":"Therapeutic alliance and rapport modulate responses to psilocybin assisted therapy for depression","volume":"12","author":"Murphy","year":"2021","journal-title":"Front Pharmacol"},{"key":"B35","doi-asserted-by":"crossref","DOI":"10.4135\/9781526405555","volume-title":"The SAGE handbook of qualitative research in psychology","author":"Willig","year":"2017"},{"key":"B36","unstructured":"audiotranskription.de: Transkribieren, Codieren & Analysieren mit f4 audiotranskription\n          \n          \n          \n          2020"},{"key":"B37","unstructured":"MAXQDA (Version MAXQDA 24)\n          \n          \n          \n          2023"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf0435","article-title":"Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors","volume":"379","author":"Vargas","year":"2023","journal-title":"Sci (New York N.Y.)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-195812000-00006","article-title":"Psychotherapy with lysergic acid diethylamide","volume":"127","author":"Eisner","year":"1958","journal-title":"J Nervous Ment Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.1020505","article-title":"Lower-dose psycholytic therapy - A neglected approach","volume":"13","author":"Passie","year":"2022","journal-title":"Front Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09540261.2024.2410853","article-title":"Psychedelic therapy \u2013 refining the claim of a paradigm shift","volume":"36","author":"Aicher","year":"2024","journal-title":"Int Rev Psychiatry"},{"key":"B42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12868-023-00809-0","article-title":"Psychedelics and neural plasticity","volume":"24","author":"Sumner","year":"2023","journal-title":"BMC Neurosci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.710004","article-title":"Critical period plasticity as a framework for psychedelic-assisted psychotherapy","volume":"15","author":"Lepow","year":"2021","journal-title":"Front Neurosci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2025.07.020","article-title":"A dose of therapy with psilocybin - A meta-analysis of the relationship between the amount of therapy hours and treatment outcomes in psychedelic-assisted therapy","volume":"96","author":"Hultgren","year":"2025","journal-title":"Gen Hosp Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211069100","article-title":"Adverse effects of psychedelics: From anecdotes and misinformation to systematic science","volume":"36","author":"Schlag","year":"2022","journal-title":"J Psychopharmacol (Oxford England)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J Psychopharmacol (Oxford England)"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1556\/2054.2023.00245","article-title":"Differences in attitudes and beliefs about psychedelic-assisted therapy among social workers, psychiatrists, and psychologists in the United States","volume":"7","author":"Armstrong","year":"2023","journal-title":"J Psychedelic Stud"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1177\/13634615221100385","article-title":"Modalities of the psychedelic experience: Microclimates of set and setting in hallucinogen research and culture","volume":"59","author":"Hartogsohn","year":"2022","journal-title":"Transcultural Psychiatry"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.680064","article-title":"Moral psychopharmacology needs moral inquiry: the case of psychedelics","volume":"12","author":"Langlitz","year":"2021","journal-title":"Front Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.0c00192","article-title":"The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects","volume":"4","author":"Olson","year":"2021","journal-title":"ACS Pharmacol Trans Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2023.1554","article-title":"Importance of integrating spiritual, existential, religious, and theological components in psychedelic-assisted therapies","volume":"80","author":"Palitsky","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"B52","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-031-65790-0_25","article-title":"Therapist, trip sitter or guide? A second-person perspective on psychedelic-assisted psychotherapy","volume-title":"The palgrave handbook of philosophy and psychoactive drug use","author":"Caporuscio","year":"2024"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1089\/psymed.2023.0074","article-title":"Understanding psychedelic-assisted psychotherapy providers\u2019 Perspective and insights: A qualitative analysis","volume":"2","author":"Smith","year":"2024","journal-title":"Psychedelic Med (New Rochelle N.Y.)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.887255","article-title":"Psychedelic-assisted psychotherapy-A systematic review of associated psychological interventions","volume":"13","author":"Cavarra","year":"2022","journal-title":"Front Psychol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.119952","article-title":"Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials","volume":"391","author":"Kittur","year":"2025","journal-title":"J Affect Disord"},{"key":"B56","unstructured":"The yale manual for psilocybin-assisted therapy of depression (using acceptance and commitment therapy as a therapeutic frame)\n          \n          \n            \n              Guss\n              J\n            \n            \n              Krause\n              R\n            \n            \n              Sloshower\n              J\n            \n          \n          \n          2020"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.873279","article-title":"Psychedelics and psychotherapy: cognitive-behavioral approaches as default","volume":"13","author":"Yaden","year":"2022","journal-title":"Front Psychol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/15294145.2019.1689528","article-title":"Seeing without self: Discovering new meaning with psychedelic-assisted psychotherapy","volume":"21","author":"Fischman","year":"2019","journal-title":"Neuropsychoanalysis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jcbs.2019.12.004","article-title":"The use of the psychological flexibility model to support psychedelic assisted therapy","volume":"15","author":"Watts","year":"2020","journal-title":"J Contextual Behav Sci"},{"key":"B60","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s44271-024-00120-6","article-title":"An Integrated theory of false insights and beliefs under psychedelics","volume":"2","author":"McGovern","year":"2024","journal-title":"Commun Psychol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.07.017","article-title":"Psychedelic pleasures: An affective understanding of the joys of tripping","volume":"49","author":"B\u00f8hling","year":"2017","journal-title":"Int J Drug Policy"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1177\/2055102920978123","article-title":"The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health","volume":"7","author":"Gandy","year":"2020","journal-title":"Health Psychol Open"},{"key":"B63","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/jmt\/thaa006","article-title":"Experience of music used with psychedelic therapy: A rapid review and implications","volume":"57","author":"O\u2019Callaghan","year":"2020","journal-title":"J Music Ther"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/7854_2025_608","article-title":"The Role and Ethics of Touch and Non-touch in Psychedelic-Assisted Therapy","author":"Aicher","year":"2025","journal-title":"Current Topics in Behavioral Neurosciences."},{"key":"B65","doi-asserted-by":"publisher","first-page":"psymed.2023.0069","DOI":"10.1089\/psymed.2023.0069","article-title":"Evolving guidelines for the use of touch during a clinical trial of group psilocybin-assisted therapy","volume":"2","author":"Back","year":"2024","journal-title":"Psychedelic Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1037\/a0014751","article-title":"Exploring the use of touch in the psychotherapeutic setting: A phenomenological review","volume":"46","author":"Phelan","year":"2009","journal-title":"Psychother (Chicago Ill.)"},{"key":"B67","unstructured":"The Ethics of Touch in Psychedelic Therapy: Explore ethical considerations of therapeutic touch in psychedelic therapy. Learn how it aids healing and the importance of clear boundaries\n          \n          \n            \n              Woolfe\n              S\n            \n          \n          \n          2024"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2020-106070","article-title":"Ethics and ego dissolution: The case of psilocybin","volume":"47","author":"Smith","year":"2020","journal-title":"J Med Ethics"},{"key":"B69","article-title":"Ending the silence around psychedelic therapy abuse","author":"Hall","year":"2021"},{"key":"B70","unstructured":"Participant experiences & \u201cCover story\u201d\n          \n          \n          \n          2022"},{"key":"B71","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/psymed.2023.0033","article-title":"Getting in touch with touch: the importance of studying touch in MDMA-assisted therapy and the development of a new self-report measure","volume":"2","author":"Luoma","year":"2024","journal-title":"Psychedelic Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2020.101921","article-title":"Therapeutic alliance as a mediator of change: A systematic review and evaluation of research","volume":"82","author":"Baier","year":"2020","journal-title":"Clin Psychol Rev"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.4103\/Indianjpsychiatry.Indianjpsychiatry_50_21","article-title":"Ethical and legal issues in psychotherapy","volume":"64","author":"Avasthi","year":"2022","journal-title":"Indian J Psychiatry"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1037\/rev0000589","article-title":"Common factors in altered states: Understanding psychedelic therapy through the lens of Grawe\u2019s general change mechanisms","volume":"132","author":"Wolff","year":"2025","journal-title":"psychol Rev"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1177\/0022167817711304","article-title":"Developing guidelines and competencies for the training of psychedelic therapists","volume":"57","author":"Phelps","year":"2017","journal-title":"J Humanistic Psychol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1997.10400190","article-title":"Set, setting, and matrix","volume":"29","author":"Eisner","year":"1997","journal-title":"J Psychoactive Drugs"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116677852","article-title":"Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology","volume":"30","author":"Hartogsohn","year":"2016","journal-title":"J Psychopharmacol (Oxford England)"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1771726\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:41:30Z","timestamp":1775022090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1771726\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":77,"alternative-id":["10.3389\/fpsyt.2026.1771726"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1771726","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"1771726"}}